Program
Tin Fluorides
Also written as “0.454% Stannous Fluoride Dentifrice”, “Stannous fluoride toothpaste” and “Stannous Fluoride”.
Its studies are mostly in Gingivitis · Dentin Sensitivity · Dental Plaque · Diabetes Mellitus, Type 2 · Halitosis, led by 5 companies.
Drug pageTin Fluorides: every studyMany companies study it; this page follows only the 47 they lead. All 44 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmoliveits history only | 182 open or running | phase 4since Feb 6, 2015 | Sep 26, 2008 | Sep 2027phase 4 · NCT07807397 |
| Procter and Gambleits history only | 142 open or running | phase 4since Aug 28, 2025 | Feb 28, 2012 | none ahead |
| GlaxoSmithKlineits history only | 80 open or running | phase 3since May 3, 2012 | May 3, 2012 | none ahead |
| HALEON | 40 open or running | no phasesince Nov 16, 2023 | Nov 16, 2023 | none ahead |
| Church & Dwightits history only | 30 open or running | no phasesince Feb 12, 2026 | Feb 12, 2026 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of HALEON only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Nov 16, 2023First study: no phase study in GingivitisFirst studyNCT06143670 · 159 enrolled · United States
- Mar 20, 2024No phase study in Dentin SensitivityNCT06359028 · 111 enrolled · United States
- Apr 3, 2024No phase study in Dentin SensitivityNCT06354270 · 115 enrolled · United States
- Oct 24, 2024No phase study in Dental PlaqueNCT06660069 · 199 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 HALEON leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06660069Dental Plaque · United States | – | Completed | Mar 11, 2025 | 199 |
| NCT06354270Dentin Sensitivity · United States | – | Completed | Jun 23, 2024 | 115 |
| NCT06359028Dentin Sensitivity · United States | – | Completed | Jun 20, 2024 | 111 |
| NCT06143670Gingivitis · United States | – | Completed | Mar 12, 2024 | 159 |
How it is read
Names in the registry
- “0.454% Stannous Fluoride Dentifrice”, 8 entries
- “Stannous fluoride toothpaste”, 7 entries
- “Stannous Fluoride”, 6 entries
- “stannous fluoride toothpaste”, 5 entries
- “Stannous Fluoride Toothpaste (SnF)”, 5 entries
Conditions, from the studies’ own filings
- Gingivitis, 20 studies
- Dentin Sensitivity, 8 studies
- Dental Plaque, 7 studies
- Diabetes Mellitus, Type 2, 1 study
- Halitosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.